Phase II Study of Panitumumab Monotherapy in Chemotherapy-Naïve Frail or Elderly Patients with Unresectable RAS Wild-Type Colorectal Cancer: OGSG 1602.
Phase II study of panitumumab monotherapy in chemotherapy-difficult or elderly patients with unresectable RAS-wild-type colorectal cancer: OGSG 1602.